LIVEFed rate decision market screenLive market screen · BTC, gold, dollar, Nasdaq second by secondWatch

Michael J. Farrell, Resmed option exercise and sale

CEO and chair, SEC Form 4, filed on September 10, 2026
$1.11 million4,991 shares, average $222.44
Transaction date
September 8, 2026
Shares held after
466,256Direct ownership
Change in holding
0.00%From the transactions in the filing
Filing rows
21 is not a purchase or sale

Price context

RMD daily close, Apr 27 to October 27, 2026
$253.20$146.34
Daily close
Sale
Grants, options, tax
Trade average $222.44
Transaction price
$222.44Weighted average
Close on trade date
$221.05September 8, 2026
Latest close
$250.72October 27, 2026
Since the trade
+12.71%vs the trade average

Transactions in the filing

DateTransactionSecuritySharesPriceAmountAfter
Option exercise
Common stockDirect
4,991
$146.34
$730,383
471,247
Sale
Common stockDirect
4,991
$222.44
$1.11 million
466,256

Recent filings at Resmed

Full history
PersonTransactionAmount or sharesDate
Michael J. RiderChief legal officer
Sale
$102,000
Michael J. FarrellCEO and chair
SaleOption exercise
$1.13 million
Peter C. FarrellDirector
Sale
$227,688
Michael J. RiderChief legal officer
Grant
+3,230 shares
Aaron BloomerCFO
Grant
+9,072 shares
Michael J. FarrellCEO and chair
Grant
+13,547 shares
Justin LeongChief product officer
Grant
+6,461 shares
Michael J. FarrellCEO and chair
SaleOption exercise
$1.03 million